Olink Holding AB announced that the UK Competition and Markets Authority (CMA) has unconditionally approved the previously announced tender offer by Orion Acquisition AB, a wholly owned subsidiary of Thermo Fisher Scientific, for all outstanding Common

Shares and American Depositary Shares of Olink for $26.00 per Share.

The Offer is being made pursuant to the Purchase Agreement, dated as of October 17, 2023, by and between Thermo Fisher and Olink. As a result of the CMA approval, Olink and Thermo Fisher expect to complete the Offer promptly following the expiration of the Offer at 5:00 p.m. Eastern time on July 9, 2024.

Completion of the Offer remains subject to the conditions set forth in the Offer to Purchase, dated October 31, 2023, including that Buyer holds Common Shares and American Depositary Shares that represent at least one Common Share more than 90% of the issued and outstanding Common Shares immediately prior to the Expiration Time (excluding Common Shares held in treasury or by subsidiaries of Olink).